EUVIMEDEUVIMED entdecken
Crossref

Rapid Selenoprotein Activation by Selenium Nanoparticles to Suppresses Osteoclastogenesis and Pathological Bone Loss

Binhua Zou, Zushuang Xiong, Yanzi Yu, Sujiang Shi, Xiaoling Li, Tianfeng Chen iD

Advanced Materials · 2024-07 · 36 (27)

DOI: 10.1002/adma.202401620 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 28.04.2024. Verfasst von Binhua Zou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Joint Surgery, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China. Hauptthemen laut MEDLINE: Selenium, Osteogenesis, Nanoparticles, Selenoproteins. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Key R&D Program of China, National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoclast hyperactivation stands as a significant pathological factor contributing to the emergence of bone disorders driven by heightened oxidative stress levels. The modulation of the redox balance to scavenge reactive oxygen species emerges as a viable approach to addressing this concern. Selenoproteins, characterized by selenocysteine (SeCys 2 ) as the active center, are crucial for selenium‐based antioxidative stress therapy for inflammatory diseases. This study reveals that surface‐active elemental selenium (Se) nanoparticles, particularly lentinan‐Se (LNT‐Se), exhibit enhanced cellular accumulation and accelerated metabolism to SeCys 2 , the primary active Se form in biological systems. Consequently, LNT‐Se demonstrates significant inhibition of osteoclastogenesis. Furthermore, in vivo studies underscore the superior therapeutic efficacy of LNT‐Se over SeCys 2 , potentially attributable to the enhanced stability and safety profile of LNT‐Se. Specifically, LNT‐Se effectively modulates the expression of the selenoprotein GPx1, thereby exerting regulatory control over osteoclastogenesis inhibition, and the prevention of osteolysis. In summary, these results suggest that the prompt activation of selenoproteins by Se nanoparticles serves to suppress osteoclastogenesis and pathological bone loss by upregulating GPx1. Moreover, the utilization of bioactive Se species presents a promising avenue for effectively managing bone disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeleniumOsteogenesisNanoparticlesSelenoproteinsOsteoclastsAnimalsMiceGlutathione Peroxidase GPX1RAW 264.7 CellsGlutathione PeroxidaseOsteolysis

Stichwörter der Autor:innen

boneosteoclastosteoporosisrheumatoid arthritisseleniumselenoproteins

Substanzen

SeleniumSelenoproteinsGlutathione Peroxidase GPX1Glutathione PeroxidaseGpx1 protein, mouse

Autor:innen und Institutionen

  • Department of Bone and Joint Surgery, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
  • Institute of Food Safety and Nutrition, Jinan University, Guangzhou, 510632, China.
  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Laboratory of Viral Pathogenesis & Infection Prevention and Control of Ministry of Education, Key Laboratory for Regenerative Me…

ORCID-Profile: Tianfeng Chen

Förderung

  • National Key R&D Program of China
  • National Science Fund for Distinguished Young Scholars
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Key Research and Development Program of China

Zitieren

APA

Zou, B., Xiong, Z., Yu, Y., Shi, S., Li, X., & Chen, T. (2024). Rapid Selenoprotein Activation by Selenium Nanoparticles to Suppresses Osteoclastogenesis and Pathological Bone Loss. Advanced Materials, 36(27). https://doi.org/10.1002/adma.202401620

Vancouver

Zou B, Xiong Z, Yu Y, Shi S, Li X, Chen T. Rapid Selenoprotein Activation by Selenium Nanoparticles to Suppresses Osteoclastogenesis and Pathological Bone Loss. Advanced Materials. 2024;36(27). doi:10.1002/adma.202401620

BibTeX
@article{Zou2024,
  author = {Zou, Binhua and Xiong, Zushuang and Yu, Yanzi and Shi, Sujiang and Li, Xiaoling and Chen, Tianfeng},
  title = {Rapid Selenoprotein Activation by Selenium Nanoparticles to Suppresses Osteoclastogenesis and Pathological Bone Loss},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {27},
  doi = {10.1002/adma.202401620}
}
Kostenlos starten →